122 related articles for article (PubMed ID: 37552203)
1. The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis.
Modemann F; Ahmadi P; von Kroge PH; Weidemann S; Bokemeyer C; Dierlamm J; Fiedler W; Ghandili S
Leuk Lymphoma; 2023; 64(11):1801-1810. PubMed ID: 37552203
[TBL] [Abstract][Full Text] [Related]
2. Bowel perforation in intestinal lymphoma: incidence and clinical features.
Vaidya R; Habermann TM; Donohue JH; Ristow KM; Maurer MJ; Macon WR; Colgan JP; Inwards DJ; Ansell SM; Porrata LF; Micallef IN; Johnston PB; Markovic SN; Thompson CA; Nowakowski GS; Witzig TE
Ann Oncol; 2013 Sep; 24(9):2439-43. PubMed ID: 23704194
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell Lymphoma.
Cortes-Bullich A; Perez A; Bachmeier C; Mhaskar R; Chavez JC; Shah B; Nishihori T; Khimani F; Lazaryan A; Davila ML; Locke FL; Jain MD
Transplant Cell Ther; 2021 Sep; 27(9):768.e1-768.e6. PubMed ID: 34077811
[TBL] [Abstract][Full Text] [Related]
4. The role of surgical management in primary small bowel lymphoma: A single-center experience.
Hong YW; Kuo IM; Liu YY; Yeh TS
Eur J Surg Oncol; 2017 Oct; 43(10):1886-1893. PubMed ID: 28751057
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analysis and prognostic factors of 11 patients with primary non-Hodgkin lymphoma of the small intestine in a single institute.
Chen JH; Ho CL; Chen YC; Chao TY; Kao WY
Oncol Lett; 2014 Aug; 8(2):876-880. PubMed ID: 25013511
[TBL] [Abstract][Full Text] [Related]
6. Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma.
Diaz JP; Tew WP; Zivanovic O; Konner J; Sabbatini PJ; dos Santos LA; Abu-Rustum NR; Chi DS; Aghajanian C; Barakat RR
Gynecol Oncol; 2010 Mar; 116(3):335-9. PubMed ID: 20004956
[TBL] [Abstract][Full Text] [Related]
7. Post-chemotherapy perforation in cats with discrete intermediate- or large-cell gastrointestinal lymphoma.
Crouse Z; Phillips B; Flory A; Mahoney J; Richter K; Kidd L
J Feline Med Surg; 2018 Aug; 20(8):696-703. PubMed ID: 28809125
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers.
Draper A; Jung EH; Cao Y; Atallah RP; Switchenko J; Kane S; Guadagno J; Jones AT; Brutcher E; Alese OB
Oncology; 2023; 101(4):213-223. PubMed ID: 36626879
[TBL] [Abstract][Full Text] [Related]
9. Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients.
Ibrahim EM; Ezzat AA; El-Weshi AN; Martin JM; Khafaga YM; Al Rabih W; Ajarim DS; Al-Foudeh MO; Zucca E
Ann Oncol; 2001 Jan; 12(1):53-8. PubMed ID: 11249049
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma.
Yan J; Duan Y; Liu T; Guo J; Peng C; Pang W; Zhang D; Peng Y; Chen Y
BMC Pediatr; 2021 Dec; 21(1):548. PubMed ID: 34863135
[TBL] [Abstract][Full Text] [Related]
11. Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study.
Bastos-Oreiro M; Gutierrez A; Iacoboni G; López Corral L; Reguera JL; Abrisqueta P; Delgado J; Terol MJ; Hernani R; Martínez N; Ortíz V; Bailen R; Gomez-Centurión I; Caballero A; Sanz J; Guerra Domínguez L; Luzardo H; Mussetti A; Jiménez-Ubieto A; Sancho JM; Sureda A; Pérez A; Barba P; Kwon M; Martín García-Sancho A
Transplant Cell Ther; 2023 Dec; 29(12):747.e1-747.e10. PubMed ID: 37659694
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
[TBL] [Abstract][Full Text] [Related]
13. Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience.
Tondini C; Giardini R; Bozzetti F; Valagussa P; Santoro A; Bertulli R; Balzarotti M; Rocca A; Lombardi F; Ferreri AJ
Ann Oncol; 1993 Dec; 4(10):831-7. PubMed ID: 8117602
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of Primary Gastrointestinal Non-Hodgkin's Lymphoma.
Wang W; Lin P; Yao H; Jia X; Sun J
Pak J Med Sci; 2017; 33(6):1406-1411. PubMed ID: 29492068
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal perforation in liver transplantation recipients: risk factors analysis from a 10-year retrospective study with an international multicenter survey about management strategies.
Al Taweel B; Cassese G; Chanques G; Bouyabrine H; Herrero A; Navarro F; Panaro F
Updates Surg; 2023 Apr; 75(3):553-561. PubMed ID: 36376559
[TBL] [Abstract][Full Text] [Related]
16. The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis.
Wullenkord R; Berning P; Niemann AL; Wethmar K; Bergmann S; Lutz M; Schliemann C; Mesters R; Keßler T; Schmitz N; Berdel WE; Lenz G; Stelljes M
Ann Hematol; 2021 Nov; 100(11):2733-2744. PubMed ID: 34477953
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes of newly diagnosed patients with HIV-associated aggressive B-cell NHL in China.
Wang C; Liu J; Lei H; Li Y; Wu J; Guo B; Hu R; Liu T; Wu J; Ding Y; Hu C; Liang S; Xiao C; Liang X; Huang D; Yang T; Zhang W; Yang Z; Li J; Nan Y; Li Q; Xiang Y; Li Z; Wu Y; Liu Y
J Cell Mol Med; 2022 Oct; 26(19):5067-5077. PubMed ID: 36056692
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma.
Ishikawa E; Nakamura M; Shimada K; Tanaka T; Satou A; Kohno K; Sakakibara A; Furukawa K; Yamamura T; Miyahara R; Nakamura S; Kato S; Fujishiro M
J Gastroenterol; 2020 Jan; 55(1):39-50. PubMed ID: 31493237
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity for CD22/CD19 chimeric antigen receptor T-cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma involving the gastrointestinal tract.
Zeng C; Cheng J; Li T; Huang J; Li C; Jiang L; Wang J; Chen L; Mao X; Zhu L; Lou Y; Zhou J; Zhou X
Cytotherapy; 2020 Mar; 22(3):166-171. PubMed ID: 32063474
[TBL] [Abstract][Full Text] [Related]
20. Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma.
Ibrahim EM; Ezzat AA; Raja MA; Rahal MM; Ajarim DS; Mann B; Baloush A; Stuart RK; Bazarbashi SN
Ann Oncol; 1999 Dec; 10(12):1441-9. PubMed ID: 10643534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
